Webinar: Flexible Cytometry Workflows for Drug Discovery Research
Overview
Cell cycle analysis and antibody discovery, are two key applications where high-throughput cytometry can deliver valuable insight into biologically relevant targets, which evaluate therapeutic drug candidates. Insights range from identifying antibodies that bind or modulate target cells, to measuring effects on proliferation and cell-cycle progression.
By combining functional screening with multiparametric cytometry, researchers can assess how candidate molecules influence cellular behavior. Thus supporting more informed decision-making across early drug discovery, assay development and screening workflows.
To meet research expectations, scientists require flexible, streamlined platform workflows, which support diverse assay types, broad reagent compatibility and high-content data generation, without creating workflow complexity.
Complete the Form to Access the Webinar
The webinar includes details of:
- How high-throughput drug discovery workflows can be simplified. Antibody discovery and cell cycle analysis examples, which demonstrate enhanced cytometry flexibilities.
- Expanded optical and reagent compatibilities that can support flexible assay design, broader application coverage, and more comprehensive data generation.
Webinar Speaker
Nicola Bevan
European BioAnalytics Application Development Manager
Sartorius
Nicola Bevan is the Manager of Application Development in the European BioAnalytics Application Development team at Sartorius. She plays a pivotal role in advancing research and development of reagents and applications, aimed at enhancing the functionality of life science instruments such as the iQue® HTS cytometer and Incucyte® live-cell analysis system. With more than 30 years of expertise, Nicola is a highly skilled cellular pharmacologist.
Her extensive career in the Pharmaceutical and Biotech sectors has equipped her with comprehensive experience in large pharma industrial screening departments, and the support of early-stage drug discovery initiatives.
